1. |
Wu WC, Drenser K, Trese M, et alRetinal phenotype–genotype correlation of pediatric patients expressing mutations in the Norrie disease gene[J]. Arch Ophthalmol20071252225230. DOI: 10.1001/archopht.125.2.225.
|
2. |
Bao Y, Yang J, Chen L, et alA novel mutation in the NDP gene is associated with familial exudative vitreoretinopathy in a southern Chinese family[J]. Genet Test Mol Biomarkers20192312850856. DOI: 10.1089/gtmb.2019.0099.
|
3. |
Retterer K, Juusola J, Cho MT, et alClinical application of whole-exome sequencing across clinical indications[J]. Genet Med2016187696704. DOI: 10.1038/gim.2015.148.
|
4. |
Huang L, Zhang L, Li X, et alOcular manifestations of Chinese patients with copy number variants in the NDP gene[J]. Mol Vis20222829.
|
5. |
Shen G, Ke J, Wang Z, et alStructural basis of the Norrin-Frizzled 4 interaction[J]. Cell Res201525910781081. DOI: 10.1038/cr.2015.92.
|
6. |
Chang TH, Hsieh FL, Zebisch M, et al. Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4, Lrp5/6, and proteoglycan[J/OL]. Elife, 2015, 4: e06554[2015-07-04]. https://europepmc.org/article/MED/26158506. DOI: 10.7554/eLife.06554.
|
7. |
Smith SE, Mullen TE, Graham D, et alNorrie disease: extraocular clinical manifestations in 56 patients[J]. Am J Med Genet A2012158819091917. DOI: 10.1002/ajmg.a.35469.
|
8. |
Michaelides M, Luthert P, Moore A, et alNorrie disease and peripheral venous insufficiency[J]. Br J Ophthalmol200488111475. DOI: 10.1136/bjo.2004.042556.
|
9. |
张琦, 赵培泉. 家族性渗出性玻璃体视网膜病变的荧光素眼底血管造影特征及其诊断价值[J]. 中华眼底病杂志, 2011, 27(3): 263-266. DOI: 10.3760/cma.j.issn.1005-1015.2011.03.015..Zhang Q, Zhao PQ. The characteristics and diagnostic value of fluorescein fundus angiography in familial exudative vitreoretinopathy[J]. Chin J Fundus Dis, 2011, 27 (3): 263-266. DOI: 10.3760/cma.j.issn.1005-1015.2011.03.015.
|
10. |
Walsh MK, Drenser KA, Capone A, et alNorrie disease vs familial exudative vitreoretinopathy[J]. Arch Ophthalmol20111296805820. DOI: 10.1001/archophthalmol.2011.131.
|
11. |
Huang L, Sun L, Li X, et al. NDP-related retinopathies: clinical phenotype of female carriers[J/OL]. Br J Ophthalmol, 2022, 2022: bjophthalmol-2021-320084[2022-03-31]. https://bjo.bmj.com/content/early/2022/03/30/bjophthalmol-2021-320084.long. DOI: 10.1136/bjophthalmol-2021-320084. [published online ahead of print].
|
12. |
Chen ZY, Battinelli E, Hendriks R, et alNorrie disease gene: characterization of deletions and possible function[J]. Genomics1993162533535. DOI: 10.1006/geno.1993.1224.
|
13. |
Clevers HWnt signaling: Ig-norrin the dogma[J]. Curr Biol20041411R436437. DOI: 10.1016/j.cub.2004.05.039.
|
14. |
Schuback DE, Chen ZY, Craig IW, et alMutations in the Norrie disease gene[J]. Hum Mutat199554285292. DOI: 10.1002/humu.1380050403.
|
15. |
Halpin C, Sims KTwenty years of audiology in a patient with Norrie disease[J]. Int J Pediatr Otorhinolaryngol2008721117051710. DOI: 10.1016/j.ijporl.2008.08.007.
|
16. |
Liu J, Zhu J, Yang J, et al. Prenatal diagnosis of familial exudative vitreoretinopathy and Norrie disease[J/OL]. Mol Genet Genomic Med, 2019, 7(1): e00503[2018-11-25]. https://europepmc.org/article/MED/30474316. DOI: 10.1002/mgg3.503.
|
17. |
Nikopoulos K, Venselaar H, Collin RW, et alOverview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP[J]. Hum Mutat2010316656666. DOI: 10.1002/humu.21250.
|